Abstract
Country-specific estimates of tobacco use among people living with HIV (PLWH) are lacking for much of sub-Saharan Africa. We aim to evaluate the association between the HIV status and tobacco product use status, frequency, and intensity, using nationally representative data from Zambia. We analyzed data from the 2018 Demographic and Health Survey conducted in Zambia among women aged 15–49 years and men aged 15–59 years. We performed logistic regression to assess the associations of HIV status, selected sociodemographic, and other characteristics with indicators of tobacco use (i.e., status, frequency, and intensity). Among women, 14.3% tested positive for HIV and 2.7% reported current smoking or tobacco use; women living with HIV were more likely to report currently smoking or using tobacco than women living without HIV (4.4% vs. 2.4%; aPR: 1.46). Among men, 8.4% tested positive for HIV and 19.5% reported current smoking; men living with HIV were more likely than men living without HIV to report current smoking (27.8% vs. 18.7%; aPR: 1.22). Several sociodemographic characteristics were associated with tobacco use, including age, residence (urban/rural), education level, employment status, and wealth index. The frequency and intensity of smoking among men who currently smoked did not differ by HIV status. Tobacco use was more likely in PLWH than those without HIV in Zambia. Our findings highlight the need to encourage and support tobacco cessation among PLWH, possibly by offering cessation services at existing intersections with health care or integrating cessation support into mHealth and other alternative models of care.
Keywords: HIV, tobacco use, tobacco smoking, Zambia
1. Introduction
The global burdens of both HIV and tobacco use are staggering; in 2019, over 1.1 billion people smoked tobacco and 38 million people were living with HIV [1,2]. People living with HIV (PLWH) are more likely to smoke cigarettes and use other types of tobacco compared to people living without HIV (PLWOH) [3,4,5], with a recent meta-analysis finding that nearly half of PLWH were current smokers and nearly one-quarter were former smokers [6]. Smoking is particularly hazardous for PLWH, as it increases the risk for developing HIV-related infections, cardiovascular disease (CVD), respiratory diseases, and cancers [7,8,9]. Where antiretroviral therapy (ART) for HIV is available, tobacco smoking results in a greater loss of life years than the HIV infection itself among PLWH who smoke [10]. The co-occurrence of HIV alongside noncommunicable diseases (NCDs) and their risk factors, such as tobacco use, has been described as a joint or synergistic epidemic [11,12].
More than two-thirds of all PLWH reside in sub-Saharan Africa (SSA), a region of the world where tobacco use has been steadily increasing [2,13]. Recent multicountry studies of tobacco use and HIV have been published using Demographic and Health Survey (DHS) data [3,4]. Murphy et al. (2019) analyzed DHS data from 25 countries in SSA and found PLWH were more likely to smoke cigarettes and use smokeless tobacco (SLT) than PLWOH [3]. Similarly, Mdege et al. (2017) analyzed DHS data from 28 low- and middle-income countries (LMIC), many of which were in SSA, and found a higher prevalence of any tobacco use and tobacco smoking among men living with HIV (MLWH) compared to men living without HIV (MLWOH); for women, they also noted a higher prevalence of SLT use among those with HIV [4]. The global and multicountry estimates described here clearly indicate an urgent need to better characterize country-specific estimates for tobacco use, NCDs, and related risk factors among PLWH. Unfortunately, these country-specific estimates are lacking for much of SSA, and for LMICs in particular [11,14,15].
The focus of our current study is Zambia, an LMIC in SSA with one of the largest populations of PLWH [16], where tobacco use has been steady over time [17,18], and with recent (2018) DHS data available on tobacco use and HIV. In Zambia, approximately 1% of women and nearly 20% of men report smoking tobacco, while about 14% of women and 7.5% of men are HIV-positive [18]. Both of the aforementioned multicountry studies included 2013–2014 data from Zambia [3,4]; however, HIV prevalence in Zambia has declined since then [3,4,18] and neither study assessed the relationship between HIV status and the frequency or intensity of tobacco use. Therefore, we aim to update previous estimates using more recent data from 2018, as well as evaluate the association between HIV status and the status, frequency, and intensity of tobacco use using nationally representative data from Zambia.
2. Materials and Methods
2.1. Data Source
We performed secondary data analyses on data from the 2018 DHS conducted in Zambia. DHS are nationally representative surveys that collect data on a variety of demographic, health, fertility, and nutrition topics. The survey is conducted among women aged 15–49 years and men aged 15–59 years [19].
The 2018 Zambia DHS (ZDHS) comprised four components: household questionnaire, woman’s questionnaire, man’s questionnaire, and biomarker questionnaire. The household questionnaire collected demographic information on members and visitors of each household, as well as household characteristics. The woman’s and man’s questionnaires collected information on demographic characteristics, knowledge and behavior related to health issues such as tobacco use, HIV and STIs, and other topics. The woman’s questionnaire collected additional information on maternal and reproductive health, maternal and child nutrition, and domestic violence. The biomarker questionnaire recorded height, weight, hemoglobin, and HIV test results [18].
The 2018 ZDHS followed a stratified two-stage sample design, consistent with standard DHS practice [19]. First clusters were selected within sampling stratum; then, households were sampled within clusters. Of the 12,943 occupied households sampled, 12,831 were interviewed, resulting in a household response rate of 99%. Women aged 15–49 years and men aged 15–59 years who were permanent residents or stayed in the household the night preceding the survey were eligible to be interviewed. Of the 14,189 women eligible, 13,683 were interviewed (response rate of 96%); of the 13,251 men eligible, 12,132 were interviewed (response rate of 92%) [18].
2.2. HIV Status
HIV status was based on results of blood tests conducted as part of the biomarker questionnaire. We categorized HIV status as HIV-positive, which included those who tested positive for either HIV-1 or HIV-2, and HIV-negative. Consistent with a previous report, those whose test results were inconclusive were considered missing [20].
2.3. Tobacco Use
Women who reported they currently smoked cigarettes or currently smoked or used any other type of tobacco every day or some days at the time of the survey were considered to currently use any tobacco (Appendix A). Because 72.6% of women who currently smoked cigarettes also used other types of tobacco, we opted not to examine these categories separately.
We created three variables to assess smoked tobacco use among men: tobacco smoking status, frequency of smoked tobacco use, and intensity of smoked tobacco use (Appendix B). For tobacco smoking status, men who reported they currently smoked tobacco every day or some days were considered to currently smoke tobacco, those who smoked tobacco every day or some days in the past but not currently were considered to have formerly smoked tobacco, and those who did not smoke tobacco currently or in the past were considered to have never smoked tobacco. We created a frequency of smoked tobacco use variable based on corresponding responses to current tobacco smoking (every day, some days, or not at all). We also calculated an intensity of smoked tobacco use variable by summing daily use of each tobacco product used and categorizing those sums as 5 or more times per day, 1–4 times per day, and <1 time per day. Some days, users were considered to use tobacco products <1 time per day, and nonusers were categorized as “do not smoke tobacco”. Every day, users who reported “less than daily” or “less than weekly” use of tobacco products were considered missing, resulting in some respondents appearing as daily tobacco smokers but missing data on intensity of smoked tobacco use.
Similar questions concerning use of SLT were also asked of men. However, due to low prevalence (1.0%) of SLT use among men, separate analyses of SLT use as an outcome were not possible. Instead, we included use of SLT (yes, no) as a covariate for analyses involving men.
2.4. Covariates
We included covariates age group (15–24 years, 25–34 years, 35–49 years, 50–59 years (men only)), residence (urban, rural), highest education level attended or completed (no education, primary, secondary or higher), employment status (currently employed, not currently employed), wealth index (lowest, lower, middle, higher, highest), and recent sexual activity (not sexually active in last 4 weeks, sexually active in last 4 weeks). To determine wealth index, households were given scores based on owned consumer goods and housing characteristics. Each household member was assigned the household score, and each person was ranked by their score. The distribution was then divided into five equal categories, or quintiles [18].
For women, we also included problems accessing health care (yes, no) and pregnancy status (currently pregnant, not currently pregnant or not sure). Women who identified at least one of the following as a big problem when sick and wanting to get medical advice or treatment were considered to have problems accessing care: getting permission to go for treatment, distance to the health facility, not wanting to go alone, having to take transport, concern that there may not be any health provider, concern that there may not be a female health provider, or rude attitude of health provider.
2.5. Statistical Analyses
For this study, we combined the 2018 woman’s, man’s, and biomarker data files, then applied weights provided with the biomarker file to calculate appropriate nationally representative estimates for HIV. We calculated descriptive statistics, including percentages and corresponding 95% confidence intervals (95% CI), for selected sociodemographic and other characteristics and indicators of tobacco use stratified by HIV status. We conducted chi-square analyses to test for significant differences in the distribution of these characteristics by HIV status; a p-value of <0.05 was considered statistically significant. We performed binary or ordinal logistic regression, as appropriate, to assess the associations of HIV status and selected sociodemographic and other characteristics with indicators of tobacco use. We used the ADJRR option on the PREDMARG statement to calculate model-adjusted prevalence ratios (PR) and 95% CIs [21]. All analyses were conducted separately for men and women. Analyses were conducted using SAS v9.4 and SAS-callable SUDAAN v11.0.
Of the initial 25,815 women and men interviewed, we excluded 1264 (4.9% (624 women and 640 men)) who either did not participate in the HIV testing portion of the survey or whose test results were inconclusive. We further excluded 30 men who reported smoking tobacco every day or some days but also indicated they did not use any of the individual smoked tobacco products. Our resulting analytic sample consisted of 13,059 women and 11,462 men.
3. Results
Overall, 14.3% of women tested HIV-positive (Table 1). Most women living with HIV (WLWH) were 35–49 years of age (47.0%), whereas most women living without HIV (WLWOH) were 15–24 years of age (46.5%). A higher proportion of WLWH resided in urban areas (66.6% vs. 43.1%), attended or completed secondary education or higher (51.3% vs. 47.3%), and were currently employed (56.8% vs. 42.9%) compared with WLWOH. A smaller proportion of WLWH had problems accessing healthcare and were currently pregnant than WLWOH (46.1% vs. 52.1% and 6.0% vs. 8.6%, respectively). Among WLWH, the proportion belonging to each wealth index quintile ranged from 8.4% in the lowest quintile to 33.8% in the higher quintile; for WLWOH, the proportion ranged from 18.4% in the middle quintile to 23.2% in the highest quintile. Over half of all women (53.0%) reported being sexually active in the last four weeks, with no difference between WLWH and WLWOH. Overall, 2.7% of women reported current tobacco use, with a higher prevalence among WLWH than WLWOH (4.4% vs. 2.4%).
Table 1.
Distribution of selected sociodemographic and other characteristics, and tobacco use, among women aged 15–49 years who were HIV-positive and HIV-negative—2018 DHS, Zambia.
| Overall (n = 13,059) |
HIV-Positive (n = 1711) |
HIV-Negative (n = 11,348) |
|
|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | |
| Total | N/A | 14.3% (13.3–15.5%) |
85.7% (84.5–86.8%) |
| Age group 1 | |||
| 15–24 years | 42.2% (41.3–43.1%) |
16.6% (14.0–19.4%) |
46.5% (45.5–47.5%) |
| 25–34 years | 29.9% (28.9–30.8%) |
36.5% (33.9–39.2%) |
28.8%(27.8–29.8%) |
| 35–49 years | 28.0% (27.1–28.8%) |
47.0% (43.7–50.3%) |
24.8% (23.9–25.7%) |
| Residence 1 | |||
| Urban | 46.5% (43.7–49.3%) |
66.6% (62.1–70.8%) |
43.1% (40.5–45.8%) |
| Rural | 53.5%(50.7–56.3%) | 33.4% (29.2–37.9%) |
56.9% (54.2–59.5%) |
| Highest education level attended or completed 1 | |||
| No education | 7.6% (6.7–8.5%) |
5.7% (4.5–7.4%) |
7.9% (7.0–8.9%) |
| Primary | 44.6% (42.7–46.5%) |
42.9% (39.7–46.2%) |
44.9% (43.0–46.8%) |
| Secondary or higher | 47.8% (45.8–49.9%) |
51.3%(47.9–54.8%) | 47.3% (45.2–49.4%) |
| Employment status 1 | |||
| Currently employed | 44.9% (43.4–46.4%) |
56.8% (53.3–60.3%) |
42.9% (41.3–44.4%) |
| Not currently employed | 55.1% (53.6–56.6%) |
43.2% (39.7–46.7%) |
57.1% (55.6–58.7%) |
| Wealth index 1 | |||
| Lowest | 17.8% (16.4–19.3%) |
8.4% (6.9–10.3%) |
19.3% (17.9–20.9%) |
| Lower | 17.6% (16.2–19.1%) |
11.6% (9.7–16.7%) |
18.6% (17.2–20.1%) |
| Middle | 18.3% (16.8–19.9%) |
17.2% (14.3–20.6%) |
18.4% (16.9–20.1%) |
| Higher | 22.4% (19.7–25.3%) |
33.8% (27.2–41.0%) |
20.5% (18.2–22.9%) |
| Highest | 24.0% (21.8–27.1%) |
29.1% (24.1–34.6%) |
23.2% (20.5–26.0%) |
| Recent sexual activity | |||
| Sexually active in last 4 weeks | 53.0% (51.6–54.4%) |
55.4% (51.4–59.3%) |
52.6% (51.2–54.0%) |
| Not sexually active in last 4 weeks | 47.0% (45.6–48.4%) |
44.6% (40.7–48.6%) |
47.4% (46.0–48.8%) |
| Problems accessing health care 1 | |||
| Yes | 51.2% (49.4–53.0%) |
46.1% (43.0–49.2%) |
52.1% (50.1–54.0%) |
| No | 48.8% (47.0–50.6%) |
53.9% (50.8–57.0%) |
47.9% (46.0–49.9%) |
| Pregnancy status 1 | |||
| Currently pregnant | 8.2% (7.7–8.8%) |
6.0% (4.8–7.5%) |
8.6% (7.9–9.4%) |
| Not currently pregnant or not sure | 91.8% (91.2–92.3%) |
94.0% (92.5–95.2%) |
91.4% (90.6–92.1%) |
| Currently use any tobacco 1 | |||
| Yes | 2.7% (2.4–3.1%) |
4.4% (3.5–5.6%) |
2.4% (2.1–2.8%) |
| No | 97.3% (96.9–97.7%) |
95.6% (94.4–96.5%) |
97.6% (97.2–97.9%) |
Abbreviations: CI—confidence interval; DHS—Demographic and Health Survey. 1 Statistically significant difference (p < 0.05) in distribution of women living with HIV and women living without HIV, based on Chi-square test.
Overall, 8.4% of men tested HIV-positive (Table 2). Most MLWH were between 35 and 49 years of age (49.8%), whereas most MLWOH were 15–24 years of age (43.1%); nearly one in five (17.0%) MLWH were 50–59 years of age, while only 7.1% of MLWOH were in this age group. Compared to MLWOH, more MLWH resided in urban areas (60.7% vs. 42.5%), attended or completed secondary education or higher (61.7% vs. 56.4%), were currently employed (88.0% vs. 74.0%), and had been sexually active in the last 4 weeks (72.1% vs. 57.0%). Among MLWH, the proportion belonging to each wealth index quintile ranged from 8.0% in the lowest quintile to 30.6% in the higher quintile; for MLWOH, the proportion ranged from 17.2% in the lowest quintile to 22.4% in the highest quintile. A small percentage (1.0%) of all men reported using SLT. Over one-quarter (27.8%) of MLWH reported they currently smoked tobacco and 12.2% formerly smoked tobacco, compared with 18.7% and 7.4%, respectively, of MLWOH. A higher proportion of MLWH reported currently smoking every day and some days than MLWOH (21.4% vs. 14.2% and 6.4% vs. 4.6%, respectively). Compared to MLWOH, more MLWH smoked tobacco 5 or more times per day (10.7% vs. 7.3%), 1–4 times per day (9.0% vs. 6.8%), and <1 time per day (6.6% vs. 4.6%).
Table 2.
Distribution of selected sociodemographic and other characteristics, and tobacco use, among men aged 15–59 who were HIV-positive and HIV-negative—2018 DHS, Zambia.
| Overall (n = 11,462) |
HIV-Positive (n = 923) |
HIV-Negative (n = 10,539) |
|
|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | |
| Total | n/a | 8.4% (7.7–9.2%) |
91.6% (90.1–92.3%) |
| Age group 1 | |||
| 15–24 years | 40.2% (39.2–41.2%) |
8.5% (6.6–11.0%) |
43.1% (41.9–44.3%) |
| 25–34 years | 25.6% (24.6–26.5%) |
24.7% (21.7–28.1%) |
25.7% (24.7–26.6%) |
| 35–49 years | 26.3% (25.2–27.4%) |
49.8% (45.9–53.7%) |
24.2% (23.0–25.3%) |
| 50–59 years | 7.9% (7.4–8.5%) |
17.0% (14.3–20.0%) |
7.1% (6.6–7.6%) |
| Residence 1 | |||
| Urban | 44.0% (41.0–47.0%) |
60.7% (55.6–65.4%) |
42.5% (39.5–45.5%) |
| Rural | 56.0% (53.0–59.0%) |
39.4% (34.6–44.4%) |
57.5% (54.5–60.5%) |
| Highest education level attended or completed 1 | |||
| No education | 3.9% (3.4–4.6%) |
2.9% (1.8–4.7%) 2 |
4.0% (3.4–4.7%) |
| Primary | 39.2% (37.6–40.9%) |
35.5% (31.6–39.5%) |
39.5% (37.9–41.2%) |
| Secondary or higher | 56.9% (55.1–58.6%) |
61.7% (57.5–65.7%) |
56.4% (54.6–58.2%) |
| Employment status 1 | |||
| Currently employed | 75.2% (73.8–76.5%) |
88.0% (84.8–90.7%) |
74.0% (72.6–75.4%) |
| Not currently employed | 24.8% (23.5–26.2%) |
12.0% (9.4–15.2%) |
26.0% (24.6–27.4%) |
| Wealth index 1 | |||
| Lowest | 16.4% (15.1–17.9%) |
8.0% (6.3–10.1%) |
17.2% (15.8–18.7%) |
| Lower | 17.9% (16.5–19.5%) |
13.2% (10.9–15.9%) |
18.4% (16.9–19.9%) |
| Middle | 20.1% (18.4–21.8%) |
18.5% (15.4–22.1%) |
20.2% (18.6–22.0%) |
| Higher | 22.6% (19.3–26.2%) |
30.6% (24.5–37.5%) |
21.9% (18.8–25.3%) |
| Highest | 23.0% (20.1–26.2%) |
29.7% (24.6–35.2%) |
22.4% (19.6–25.5%) |
| Recent sexual activity 1 | |||
| Sexually active in last 4 weeks | 58.2% (57.0–59.5%) |
72.1% (68.3–75.6%) |
57.0% (55.6–58.3%) |
| Not sexually active in last 4 weeks | 41.8% (40.5–43.0%) |
27.9% (24.4–31.8%) |
43.1% (41.7–44.4%) |
| Current smokeless tobacco use | |||
| Yes | 1.0% (0.7–1.3%) |
- 3 | 0.9% (0.7–1.2%) |
| No | 99.1% (98.7–99.3%) |
- 3 | 99.1% (98.8–99.4%) |
| Tobacco smoking status 1 | |||
| Currently smoke tobacco | 19.5% (18.4–20.7%) |
27.8% (24.6–31.3%) |
18.7% (17.6–19.9%) |
| Formerly smoked tobacco | 7.8% (7.1–8.6%) |
12.2% (9.8–15.0%) |
7.4% (6.7–8.2%) |
| Never smoked tobacco | 72.7% (71.2–74.2%) |
60.0% (55.9–64.0%) |
73.9% (72.3–75.3%) |
| Frequency of smoked tobacco use 1 | |||
| Every day | 14.8% (13.9–15.7%) |
21.4% (18.4–24.6%) |
14.2% (13.2–15.1%) |
| Some days | 4.7% (4.2–5.3%) |
6.4% (4.8–8.7%) |
4.6% (4.1–5.2%) |
| Not at all | 80.5% (79.3–81.6%) |
72.2% (68.7–75.4%) |
81.3% (80.1–82.4%) |
| Intensity of smoked tobacco use 1 | |||
| 5 or more times per day | 7.6% (6.9–8.4%) |
10.7% (8.7–13.3%) |
7.3% (6.7–8.1%) |
| 1–4 times per day | 6.9% (6.4–7.6%) |
9.0% (7.1–11.4%) |
6.8% (6.2–7.4%) |
| <1 time per day | 4.8% (4.2–5.3%) |
6.6% (4.9–8.8%) |
4.6% (4.1–5.2%) |
| Do not smoke tobacco | 80.7% (79.5–81.9%) |
73.7% (69.9–77.1%) |
81.4% (80.2–82.5%) |
Abbreviations: CI—confidence interval; DHS—Demographic and Health Survey. 1 Statistically significant difference (p < 0.05) in distribution of men living with HIV and men living without HIV, based on Chi-square test. 2 Estimate based on 25–49 unweighted cases. 3 Data suppressed because the estimate was based on fewer than 25 unweighted cases.
WLWH were more likely to currently use tobacco than WLWOH (aPR: 1.46) (Table 3). The prevalence of current tobacco use among women increased with an increasing age (0.9% (15–24 years) to 4.9% (35–49 years)). In general, the prevalence of current tobacco use among women decreased with an increasing education level (6.1% (no education) to 1.8% (secondary or higher)) and wealth index (4.4% (lowest) to 1.7% (highest)). After adjustment for covariates, the prevalence of current tobacco use was significantly higher among women in higher age groups (aPRs: 3.01 (25–34 years), 4.16 (35–49 years)), who resided in urban areas (aPR: 1.78), had no education (aPR: 1.79), and were in the lowest to middle wealth index quintiles (aPRs ranged from 3.87 (lowest) to 1.83 (middle)), compared to those who were 15–24 years of age, resided in rural areas, had completed secondary or higher education, and were in the highest wealth index quintile.
Table 3.
Prevalence and adjusted prevalence ratios (APRs) for HIV status and selected characteristics with any current tobacco use among women—2018 DHS, Zambia.
| Currently Smoke or Use Any Tobacco (n = 384) | ||
|---|---|---|
| % (95% CI) | APR (95% CI) | |
| HIV status | ||
| HIV-positive | 4.4% (3.5–5.6%) |
1.46 (1.09–1.96) 1 |
| HIV-negative | 2.4% (2.1–2.8%) |
Ref |
| Age group | ||
| 15–24 years | 0.9% (0.6–1.2%) |
Ref |
| 25–34 years | 3.2% (2.6–3.9%) |
3.01 (2.11–4.30) 1 |
| 35–49 years | 4.9% (4.1–5.8%) |
4.16 (2.85–6.07) 1 |
| Residence | ||
| Urban | 2.5% (2.0–3.0%) |
1.78 (1.20–2.63) 1 |
| Rural | 2.9% (2.4–3.4%) |
Ref |
| Highest education level attended or completed | ||
| No education | 6.1% (4.6–8.0%) |
1.79 (1.22–2.63) 1 |
| Primary | 3.1% (2.6–3.7%) |
1.16 (0.87–1.55) |
| Secondary or higher | 1.8% (1.4–2.2%) |
Ref |
| Employment status | ||
| Currently employed | 3.5% (3.0–4.1%) |
1.24 (0.95–1.62) |
| Not currently employed | 2.0% (1.6–2.5%) |
Ref |
| Wealth index | ||
| Lowest | 4.4% (3.5–5.5%) |
3.87 (2.18–6.88) 1 |
| Lower | 2.7% (2.1–3.6%) |
2.39 (1.36–4.20) 1 |
| Middle | 2.5% (1.8–3.3%) |
1.83 (1.09–3.09) 1 |
| Higher | 2.6% (1.9–3.4%) |
1.49 (0.92–2.40) |
| Highest | 1.7% (1.2–2.4%) 2 |
Ref |
| Recent sexual activity | ||
| Sexually active in last 4 weeks | 3.3% (2.8–3.9%) |
1.23 (0.95–1.61) |
| Not sexually active in last 4 weeks | 2.0% (1.6–2.5%) |
Ref |
| Problems accessing health care | ||
| Yes | 2.8% (2.3–3.3%) |
Ref |
| No | 2.6% (2.1–3.2%) |
1.05 (0.81–1.36) |
| Pregnancy status | ||
| Currently pregnant | 2.0% (1.3–3.1%) 2 |
Ref |
| Not currently pregnant or not sure | 2.8% (2.4–3.1%) |
1.24 (0.81–1.90) |
Abbreviations: CI—confidence interval; DHS—Demographic and Health Survey; PR—prevalence ratio; APR—adjusted prevalence ratio. 1 Statistically significant based on confidence interval for APR not including 1.0. 2 Estimate based on 25–49 unweighted cases.
MLWH were more likely than MLWOH to report current or former tobacco smoking (aPR: 1.22 and 1.12, respectively) (Table 4). The prevalence of current tobacco smoking was 27.8% among MLWH, 31.6% among men aged 50–59 years, 21.1% among men residing in rural areas, 27.6% among men with no education, 30.1% among those in the lowest wealth index quintile, and 70.4% among men currently using SLT. After adjusting for covariates, the prevalence of current smoking was significantly higher among MLWH (aPR: 1.22), men residing in urban areas (aPR: 1.63), with no or primary education (aPRs: 1.26 and 1.25, respectively), who were currently employed (aPR: 1.32), and who currently used SLT (aPR: 3.54), compared to MLWOH, men residing in rural areas, who had completed secondary or higher education, who were not currently employed, and who did not currently use SLT. The prevalence of current tobacco smoking increased with the increasing age group (aPRs ranged from 2.17 (25–34 years) to 2.76 (50–59 years)) and decreasing wealth index quintile (aPRs ranged from 1.28 (higher) to 2.62 (lowest)) compared to men 15–24 years of age and in the highest wealth index quintile. The prevalence of former tobacco smoking was 12.2% among MLWH, 10.7% among men aged 50–59 years, and 8.2% among men with secondary or higher education. After adjusting for covariates, the prevalence of former tobacco smoking was significantly higher among MLWH (aPR: 1.12), men residing in urban areas (aPR: 1.32), with no or primary education (aPRs: 1.15 and 1.15, respectively), and who were currently employed (aPR: 1.19), compared to MLWOH, men residing in rural areas, who had completed secondary or higher education, and who were not currently employed. The prevalence of former tobacco smoking increased with an increasing age (aPRs ranged from 1.73 (25–34 years) to 1.95 (50–59 years)) and decreasing wealth index (aPRs ranged from 1.20 (higher) to 1.77 (lowest)), compared to men 15–24 years of age and those in the highest wealth index quintile.
Table 4.
Prevalence and adjusted prevalence ratios (APRs) for HIV status and selected characteristics with tobacco smoking status, frequency of smoked tobacco use, and intensity of smoked tobacco use among men—2018 DHS, Zambia.
| Tobacco Smoking Status | Frequency of Smoked Tobacco Use 1 | Intensity of Smoked Tobacco Use 1 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currently Smoke Tobacco (n = 2338) |
Formerly Smoked Tobacco (n = 843) |
Every Day (n = 1776) |
Some Days (n = 562) |
Five or More Times per Day (n = 902) |
1–4 Times per Day (n = 856) |
<1 Time per Day (n = 562) |
||||||||
| % (95% CI) | APR (95% CI) | % (95% CI) | APR (95% CI) | % (95% CI) | APR (95% CI) | % (95% CI) | APR (95% CI) | % (95% CI) | APR (95% CI) | % (95% CI) | APR (95% CI) |
% (95% CI) | APR (95% CI) | |
| HIV status | ||||||||||||||
| HIV-positive | 27.8% (24.6–31.3%) |
1.22 (1.08–1.37) 2 |
12.2% (9.85–15.0%) |
1.12 (1.05–1.19) 2 |
76.8% (69.9–82.6%) |
1.02 (0.94–1.11) |
23.2% (17.4–30.1%) |
0.94 (0.71–1.24) |
40.8% (34.1–47.9%) |
0.97 (0.80–1.16) |
34.3% (28.1–41.0%) |
1.01 (0.97–1.04) |
25.0% (19.1–31.8%) |
1.04 (0.84–1.30) |
| HIV-negative | 18.7% (17.6–19.9%) |
Ref | 7.4% (6.7–8.2%) |
Ref | 75.6% (73.1–77.9%) |
Ref | 24.4% (22.1–26.9%) |
Ref | 39.3% (36.7–41.9%) |
Ref | 36.2% (33.5–39.0%) |
Ref | 24.6% (22.3–27.1%) |
Ref |
| Age group | ||||||||||||||
| 15–24 years | 8.0% (6.9–9.1%) |
Ref | 6.3% (5.4–7.4%) |
Ref | 63.7% (57.0–69.9%) |
Ref | 36.3% (30.1–43.0%) |
Ref | 26.2% (21.3–31.8%) |
Ref | 36.7% (30.6–43.3%) |
Ref | 37.1% (30.6–44.1%) |
Ref |
| 25–34 years | 24.7% (22.6–26.9%) |
2.17 (1.89–2.51) 2 |
8.3% (7.1–9.8%) |
1.73 (1.56–1.92) 2 |
70.9% (67.0–74.6%) |
1.07 (0.97–1.19) |
29.1% (25.4–33.0%) |
0.85 (0.68–1.06) |
35.5% (31.5–39.8%) |
1.33 (1.08–1.63) 2 |
34.8% (30.6–39.3%) |
1.00 (0.98–1.03) |
29.7% (26.1–33.5%) |
0.76 (0.62–0.92) 2 |
| 35–49 years | 28.5% (26.4–30.7%) |
2.38 (2.06–2.75) 2 |
8.8% (7.6–10.1%) |
1.82 (1.64–2.02) 2 |
81.9% (78.6–84.9%) |
1.19 (1.09–1.31) 2 |
18.1% (15.2–21.4%) |
0.60 (0.47–0.76) 2 |
45.6% (41.7–49.6%) |
1.71 (1.40–2.09) 2 |
36.2% (32.5–40.1%) |
0.93 (0.86–0.98) 2 |
18.2% (15.2–21.6%) |
0.55 (0.44–0.67) 2 |
| 50–59 years | 31.6% (28.3–35.1%) |
2.76 (2.36–3.23) 2 |
10.7% (8.6–13.3%) |
1.95 (1.76–2.17) 2 |
84.6% (79.5–88.6%) |
1.21 (1.09–1.34) 2 |
15.4% (11.4–20.5%) |
0.56 (0.40–0.79) 2 |
47.4% (40.2–54.6%) |
1.75 (1.40–2.18) 2 |
37.1% (29.7–45.2%) |
0.92 (0.86–1.00) |
15.6% (11.5–20.7%) |
0.53 (0.41–0.68) 2 |
| Residence | ||||||||||||||
| Urban | 17.5% (15.8–19.5%) |
1.63 (1.41–1.88) 2 |
9.0% (7.8–10.4%) |
1.32 (1.22–1.42) 2 |
70.8% (66.1–75.1%) |
1.02 (0.94–1.10) |
29.2% (24.9–33.9%) |
0.95 (0.74–1.22) |
41.3% (37.1–45.6%) |
1.08 (0.93–1.26) |
28.7% (24.0–33.9%) |
0.98 (0.94–1.02) |
30.0% (25.8–34.6%) |
0.91 (0.75–1.10) |
| Rural | 21.1% (19.7–22.5%) |
Ref | 6.9% (6.0–8.0%) |
Ref | 78.9% (76.4–81.3%) |
Ref | 21.1% (18.7–23.6%) |
Ref | 38.2% (35.3–41.3%) |
Ref | 40.6% (37.8–43.5%) |
Ref | 21.2% (18.8–23.7%) |
Ref |
| Highest education level attended or completed |
||||||||||||||
| No education | 27.6% (22.5–33.4%) |
1.26 (1.04–1.52) 2 |
7.5% (5.0–11.0%) 3 |
1.15 (1.03–1.28) 2 |
- 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 |
| Primary | 25.0% (23.3–26.8%) |
1.25 (1.13–1.39) 2 |
7.2% (6.3–8.3%) |
1.15 (1.08–1.22) 2 |
81.9% (78.9–84.5%) |
1.16 (1.08–1.25) 2 |
18.1% (15.5–21.1%) |
0.64 (0.51–0.79) 2 |
41.7% (38.2–45.3%) |
1.26 (1.09–1.46) 2 |
39.8% (36.5–43.3%) |
0.95 (0.92–0.98) 2 |
18.5% (15.8–21.4%) |
0.75 (0.63–0.90) 2 |
| Secondary or higher | 15.1% (13.7–16.7%) |
Ref | 8.2% (7.4–9.2%) |
Ref | 66.5% (62.5–70.3%) |
Ref | 33.5% (29.7–37.5%) |
Ref | 35.8% (32.2–39.6%) |
Ref | 30.3% (27.0–33.9%) |
Ref | 33.8% (30.1–37.9%) |
Ref |
| Employment status | ||||||||||||||
| Currently employed | 22.7% (21.4–24.1%) |
1.32 (1.16–1.50) 2 |
8.6% (7.8–9.5%) |
1.19 (1.09–1.30) 2 |
76.2% (73.7–78.6%) |
1.00 (0.92–1.09) |
23.8% (21.5–26.3%) |
0.99 (0.76–1.30) |
39.2% (36.5–41.9%) |
0.95 (0.79–1.14) |
36.7% (34.1–39.5%) |
1.01 (0.96–1.07) |
24.1% (21.8–26.6%) |
1.07 (0.84–1.36) |
| Not currently employed | 9.7% (8.3–11.4%) |
Ref | 5.5% (4.3–6.9%) |
Ref | 72.3% (64.7–78.7%) |
Ref | 27.8% (21.3–35.3%) |
Ref | 41.3% (34.2–48.8%) |
Ref | 30.5% (23.4–38.7%) |
Ref | 28.2% (21.7–35.8%) |
Ref |
| Wealth index | ||||||||||||||
| Lowest | 30.1% (27.9–32.4%) |
2.62 (2.13–3.22) 2 |
6.5% (5.3–8.0%) |
1.77 (1.55–2.02) 2 |
80.6% (76.7–84.0%) |
1.04 (0.91–1.19) |
19.4% (16.1–23.3%) |
0.89 (0.59–1.34) |
37.0% (32.8–41.4%) |
0.94 (0.71–1.24) |
43.5% (39.2–47.9%) |
1.01 (0.94–1.09) |
19.5% (16.1–23.4%) |
1.08 (0.76–1.53) |
| Lower | 23.8% (21.6–26.2%) |
2.16 (1.76–2.64) 2 |
7.2% (5.7–8.9%) |
1.63 (1.42–1.87) 2 |
82.6% (78.4–86.2%) |
1.07 (0.95–1.21) |
17.4% (13.8–21.6%) |
0.79 (0.53–1.18) |
41.6% (37.0–46.4%) |
1.02 (0.78–1.34) |
40.9% (36.5–45.5%) |
0.99 (0.92–1.07) |
17.5% (13.9–21.8%) |
0.97 (0.68–1.37) |
| Middle | 18.7% (16.6–20.9%) |
1.66 (1.36–2.02) 2 |
6.9% (5.7–8.2%) |
1.41 (1.23–1.62) 2 |
71.5% (66.2–76.3%) |
0.96 (0.85–1.09) |
28.5% (23.7–33.8%) |
1.11 (0.78–1.57) |
36.4% (31.9–41.3%) |
0.88 (0.67–1.14) |
35.0% (30.0–40.4%) |
1.03 (0.96–1.10) |
28.6% (23.8–33.9%) |
1.17 (0.84–1.63) |
| Higher | 17.0% (15.1–19.0%) |
1.28 (1.07–1.54) 2 |
9.0% (7.3–11.0%) |
1.20 (1.05–1.37) 2 |
71.6% (65.4–77.1%) |
1.01 (0.91–1.12) |
28.4% (22.9–34.6%) |
0.97 (0.71–1.33) |
42.1% (36.0–48.4%) |
1.00 (0.77–1.31) |
28.8% (22.6–35.8%) |
1.00 (0.93–1.08) |
29.2% (24.2–34.8%) |
1.00 (0.70–1.41) |
| Highest | 11.8% (10.0–13.9%) |
Ref | 8.9% (7.4–10.7%) |
Ref | 67.7% (59.4–75.0%) |
Ref | 32.3% (25.1–40.6%) |
Ref | 40.9% (32.8–49.6%) |
Ref | 25.6% (18.2–34.8%) |
Ref | 33.5% (25.9–42.1%) |
Ref |
| Recent sexual activity | ||||||||||||||
| Sexually active in last 4 weeks | 24.1% (22.7–25.7%) |
1.02 (0.93–1.12) |
8.9% (8.0–9.9%) |
1.01 (0.96–1.07) |
77.3% (74.7–79.8%) |
1.03 (0.96–1.10) |
22.7% (20.2–25.4%) |
0.92 (0.76–1.13) |
39.8% (36.9–42.8%) |
1.03 (0.90–1.18) |
37.3% (34.3–40.4%) |
0.99 (0.96–1.02) |
22.9% (20.5–25.6%) |
0.96 (0.81–1.14) |
| Not sexually active in last 4 weeks |
13.0% (11.7–14.4%) |
Ref | 6.3% (5.4–7.3%) |
Ref | 71.5% (67.0–75.7%) |
Ref | 28.5% (24.3–33.1%) |
Ref | 38.5% (34.0–43.2%) |
Ref | 32.5% (28.2–37.0%) |
Ref | 29.0% (24.8–33.7%) |
Ref |
| Current smokeless tobacco use | ||||||||||||||
| Yes | 70.4% (56.7–81.2%) |
3.54 (2.95–4.25) 2 |
- 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 | - 4 |
| No | 19.0% (17.9–20.2%) |
Ref | 7.8% (7.0–8.6%) |
Ref | 76.1% (73.6–78.4%) |
Ref | 23.9% (21.6–26.4%) |
Ref | 39.6% (37.1–42.2%) |
Ref | 36.2% (33.6–38.8%) |
Ref | 24.3% (22.0–26.7%) |
Ref |
Abbreviations: CI—confidence interval; DHS—Demographic and Health Survey; PR—prevalence ratio; APR—adjusted prevalence ratio. 1 Among current smokers only. 2 Statistically significant based on confidence interval for APR not including 1.0. 3 Estimate based on 25–49 unweighted cases. 4 Data suppressed because the estimate was based on fewer than 25 unweighted cases.
Among men who currently smoked, the frequency of smoked tobacco use varied by selected characteristics. MLWH had a similar prevalence of smoking tobacco every day and some days as MLWOH (76.8% vs. 75.6% and 23.2% vs. 24.4%, respectively) (Table 4). The prevalence of every day smoking was 84.6% among men aged 50–59 years, 81.9% among those with primary education, and 82.6% among those in the lower wealth index quintile. After adjusting for covariates, the prevalence of every day smoking was significantly higher among men in higher age groups (aPRs: 1.19 (35–49 years), 1.21 (50–59 years)) and who had completed primary education (aPR: 1.16), compared with those aged 15–24 years and who had completed secondary or higher education. The prevalence of some days smoking was 36.3% among those 15–24 years of age and 33.5% among those with secondary or higher education. The prevalence of some days smoking was significantly lower among men in higher age groups (aPRs: 0.60 (35–49 years), 0.56 (50–59 years)) and who had completed primary education (aPR: 0.64).
Among men who currently smoked, the intensity of smoked tobacco use varied by selected characteristics. The prevalence of smoking tobacco ≥5 times per day (40.8% vs. 39.3%), 1–4 times per day (34.3% vs. 36.2%), and <1 time per day (25.0% vs. 24.6%) was similar among MLWH and MLWOH (Table 4). The prevalence of smoking tobacco ≥5 times per day increased with an increasing age (range: 26.2% (15–24 years) to 47.4% (50–59 years)); conversely, smoking tobacco <1 time per day decreased with an increasing age (37.1% (15–24 years) to 15.6% (50–59 years)). Approximately one-third of men who completed secondary or higher education used smoked tobacco ≥5 times per day, 1–4 times per day, and <1 time per day (35.8%, 30.3%, and 33.8%, respectively). After adjusting for covariates, the prevalence of smoking tobacco ≥5 times per day was significantly higher among men in higher age groups (aPRs: 1.33 (25–34 years), 1.71 (35–49 years), 1.75 (50–59 years)) and among those who had completed primary education (aPR: 1.26), compared with those aged 15–24 years and who had completed secondary or higher education. Men aged 35–49 years (aPR: 0.93) and with primary education (aPR: 0.95) were less likely to use smoked tobacco 1–4 times per day; men in higher age groups (aPR: 0.76 (25–34 years), 0.55 (35–49 years), 0.53 (50–59 years)) and with primary education (aPR: 0.75) were also less likely to use smoked tobacco <1 time per day.
4. Discussion
We found that tobacco use and tobacco smoking were more likely among WLWH and MLWH, respectively, than PLWOH in Zambia; however, the frequency and intensity of tobacco smoking among men who currently smoked did not differ by HIV status. Several sociodemographic factors were also associated with tobacco use in these populations. Information gleaned from this study can help inform the development of programs and policies that encourage and support tobacco use cessation among PLWH in Zambia.
We found that HIV was significantly associated with current tobacco use in women and current tobacco smoking in men, a finding which aligned with previously published literature [3,4,5,6]. However, among men who currently smoked tobacco, HIV was not associated with either the frequency or intensity of smoked tobacco use (we were unable to assess these measures for women). It is possible that the sample sizes in these categories were too small to detect significant differences; however, aPRs for these associations were all near the null value of 1.0. Alternatively, the lack of association noted in these measures may indicate that current smokers living with and without HIV are not significantly different in terms of the frequency and intensity of tobacco smoking. Few studies have assessed the frequency or intensity of tobacco smoking among PLWH who smoke; Asfar et al. (2021) found that in the US, the number of cigarettes smoked per day by PLWH was lower than by PLWOH (9.9 vs. 18.2, respectively) [5], while Mdege et al. (2021) found that PLWH in Uganda reported an average of 5.2 manufactured cigarettes smoked per day [22]. It is known that the number of cigarettes smoked per day does not fully capture the intensity of smoking, given interindividual differences in the depth of smoke inhalation and related measures [23]. A higher intensity of smoking has, however, been linked to higher levels of inflammatory biomarkers, such as C-reactive protein, which in turn is associated with an increased risk of morbidity and mortality among PLWH [24]; therefore, PLWH who smoke tobacco may benefit from support to reduce the frequency or intensity of smoking until they are able to quit smoking altogether.
We identified several sociodemographic characteristics that were associated with tobacco use among women and tobacco smoking among men, including age, residence (urban/rural), education level, employment status, and wealth index. Our findings were consistent with previous studies which also demonstrated that those in older age groups [25,26,27], with lower levels of education [3,25,28,29,30,31,32], employment such as household service, manual, or agricultural work [3,30,31], or lower wealth [3,32] were more likely to use tobacco. Perhaps paradoxically, we found that tobacco use was more prevalent among residents of rural areas; however, once we controlled for other sociodemographic characteristics in logistic regression models, residents of urban areas were more likely to use or smoke tobacco. Prior studies have noted a higher smoking prevalence in rural areas of Zambia; nearly 40% in males and 10% in females in the rural districts of Kaoma and Kasama [33], and approximately 18% in males and 2% in females in the urban district of Lusaka [34]. Other studies conducted using DHS data from SSA, which included data from Zambia, have found urban residents more likely to use or smoke tobacco [30,31]. This discrepancy could be explained, in part, by underlying differences in characteristics of urban and rural residents in Zambia such as age and education level [33,34], or economic factors that may influence the access to and availability of tobacco products [35]. Among men who currently smoked, older age and a lower education level were also associated with smoking tobacco every day and smoking tobacco five or more times per day. Previous literature has shown mixed results for predictors of smoking intensity, depending on whether measures were categorical or continuous, and further study is warranted [30,31]. Finally, although a prior study found an association between recent sexual activity and tobacco use [3], ours did not; future research may be needed to elucidate this relationship.
The findings of this study are relevant to ongoing efforts in SSA and around the world to integrate cessation support into health systems serving PLWH. Though not significant in logistic regression models, WLWH less frequently reported problems accessing health care than WLWOH. This might present an opportunity to promote cessation through existing healthcare visits, and to continue to expand access to health care for all women. This frequency of healthcare system engagement among PLWH has previously been identified as a potential facilitator of cessation support for PLWH [36]. Additionally, some previous studies suggest PLWH may be more inclined to quit smoking after receiving their HIV diagnosis, enrolling in an HIV clinic, or initiating ART [28,37]. Kintu et al. (2020) recommended gradually integrating NCD care, including tobacco use screening and counseling, into existing HIV services in SSA [14]. The Zambia Consolidated Guidelines for the Treatment and Prevention of HIV Infection (2020) offers smoking cessation as a possible intervention to prevent and manage CVD, and recommends counseling for “positive living” at every routine visit for PLWH, including “nutrition, alcohol, and smoking cessation” [38]. To our knowledge, no study has evaluated these recommendations; however, studies of smoking cessation interventions in HIV clinics in LMICs are underway [39,40]. Applicable lessons learned for the integration of tobacco cessation counseling into routine clinical care for PLWH may also be available within the experience of cessation integration in care for people with tuberculosis [41]. It may also be possible to implement integrated care along with broader health system reforms which expand care to the general population, increase the use of mHealth technologies, or offer tobacco screening and cessation services in mobile clinics or home-based care [14,42]. Overcoming barriers to offering cessation for PLWH wherever possible is imperative, as even nonsustained periods of abstinence have proven benefits [36].
This study was subject to several limitations. First, except for data on HIV status, data included in this study were self-reported by participants, which could result in social desirability or recall biases. Second, data gleaned from DHS were cross-sectional in nature and, therefore, causality could not be determined. Third, data were not available for several factors, which may be related to either HIV or tobacco use, including ART [28], mental health [5,22,25,32], and substance use [5,22,28,30,32]; thus, we were unable to account for these factors. Additional health indicators, such as domestic violence or maternal health, may also be associated with HIV or tobacco use; the inclusion of these indicators was beyond the scope of the current study but may warrant future exploration. We were also unable to fully assess SLT use due to small sample sizes, though we did control for it in analyses among men. Fourth, due to the low prevalence of tobacco use reported, we were unable to assess cigarette smoking and other types of tobacco use separately among women. This may also have resulted in weaker associations for some of the factors we assessed in women; this was not unexpected, as tobacco use has consistently been found to be lower in women than men in SSA [4,25,26,43]. Finally, due to the design of DHS, we included limited ages in this study; there were, therefore, inherent limitations in our ability to depict the relationship between age and tobacco use, particularly for older adults. Despite these limitations, to our knowledge, this was the first study using nationally representative DHS data to evaluate the relationship between HIV and other factors with tobacco use in women and men in Zambia.
5. Conclusions
Tobacco use and tobacco smoking were more likely in WLWH and MLWH, respectively, than PLWOH in Zambia; however, among men who currently smoked tobacco, the frequency and intensity of smoking did not differ by HIV status. Several other sociodemographic factors were also associated with tobacco use in these populations. Our findings highlight the importance of encouraging and supporting tobacco cessation among PLWH, possibly by offering cessation services at existing intersections with health care, tailoring cessation interventions and campaigns separately to rural and urban audiences, and integrating cessation support into mHealth and other alternative models of care. Additionally, given that smoking is on the rise among women [43] and women account for a large proportion of new HIV infections in SSA [2], additional efforts to curb tobacco use in WLWH may be warranted.
Acknowledgments
The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Appendix A
Responses to the following questions were used to create tobacco-related variables for women: “Do you currently smoke cigarettes every day, some days, or not at all?” and “Do you currently smoke or use any other type of tobacco every day, some days, or not at all?”.
Appendix B
Responses to the following questions were used to create tobacco-related variables for men: “Do you currently smoke tobacco every day, some days, or not at all?”, “In the past, have you ever smoked tobacco every day, some days, or not at all?”, and “On average, how many (manufactured cigarettes/hand-rolled cigarettes/pipes full of tobacco/cigars, cheroots, or cigarillos/number of water pipe (shisha) sessions/other types of tobacco) do you currently smoke each day?”.
Author Contributions
Conceptualization, A.C.K. and E.T.; methodology, A.C.K.; formal analysis, A.C.K.; writing—original draft preparation, A.C.K., C.S., F.M.G., M.M.P. and E.T.; writing—review and editing, A.C.K., C.S., F.M.G., M.M.P. and E.T.; supervision, E.T. All authors have read and agreed to the published version of the manuscript.
Funding
The APC was funded by the CDC Foundation.
Institutional Review Board Statement
The 2018 Zambia Demographic and Health Survey was approved by the ICF Institutional Review Board and Tropical Diseases Research Centre Institutional Review Board. Because deidentified secondary data were used, this study was considered exempt from CDC institutional review board approval.
Informed Consent Statement
Informed consent was obtained from participants of the 2018 Zambia Demographic and Health Survey; see: https://dhsprogram.com/Methodology/Protecting-the-Privacy-of-DHS-Survey-Respondents.cfm (accessed on 11 February 2022).
Data Availability Statement
Restrictions apply to the availability of these data. Data were obtained with permission from the Demographic and Health Surveys (DHS) Program. Available online: https://www.dhsprogram.com (accessed on 11 February 2022).
Conflicts of Interest
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Global Burden of Disease 2019 Tobacco Collaborators Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397:2337–2360. doi: 10.1016/S0140-6736(21)01169-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.The Global HIV/AIDs Epidemic. 2021. [(accessed on 6 June 2021)]. Available online: https://www.kff.org/global-health-policy/fact-sheet/the-global-hivaids-epidemic/
- 3.Murphy J.D., Liu B., Parascandola M. Smoking and HIV in Sub-Saharan Africa: A 25-Country Analysis of the Demographic Health Surveys. Nicotine Tob. Res. 2018;21:1093–1102. doi: 10.1093/ntr/nty176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mdege N.D., Shah S., Ayo-Yusuf O.A., Hakim J., Siddiqi K. Tobacco use among people living with HIV: Analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob. Health. 2017;5:e578–e592. doi: 10.1016/s2214-109x(17)30170-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Asfar T., Perez A., Shipman P., Carrico A.W., Lee D.J., Alcaide M.L., Jones D.L., Brewer J., Koru-Sengul T. National Estimates of Prevalence, Time-Trend, and Correlates of Smoking in US People Living with HIV (NHANES 1999–2016) Nicotine Tob. Res. 2021;23:1308–1317. doi: 10.1093/ntr/ntaa277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lindayani L., Yeh C.-Y., Ko W.-C., Ko N.-Y. High smoking prevalence among HIV-positive individuals: A systematic review and meta-analysis. J. Subst. Use. 2020;25:1–10. doi: 10.1080/14659891.2019.1652364. [DOI] [Google Scholar]
- 7.Pacek L.R., Cioe P.A. Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV. Curr. HIV/AIDS Rep. 2015;12:413–420. doi: 10.1007/s11904-015-0281-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Raposeiras-Roubín S., Abu-Assi E., Iñiguez-Romo A. Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV. Curr. Opin. HIV AIDS. 2017;12:523–527. doi: 10.1097/coh.0000000000000407. [DOI] [PubMed] [Google Scholar]
- 9.Smoking and HIV. [(accessed on 12 July 2021)]; Available online: https://www.cdc.gov/tobacco/campaign/tips/diseases/smoking-and-hiv.html.
- 10.Helleberg M., May M.T., Ingle S.M., Dabis F., Reiss P., Fätkenheuer G., Costagliola D., D’Arminio A., Cavassini M., Smith C., et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29:221–229. doi: 10.1097/qad.0000000000000540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Peprah E., Armstrong-Hough M., Cook S., Mukasa B., Taylor J., Xu H., Chang L., Gyamfi J., Ryan N., Ojo T., et al. An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa. Int. J. Environ. Res. Public Health. 2021;18:3111. doi: 10.3390/ijerph18063111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Geneau R., Hallen G. Toward a systemic research agenda for addressing the joint epidemics of HIV/AIDS and noncommunicable diseases. AIDS. 2012;26((Suppl. 1)):S7–S10. doi: 10.1097/QAD.0b013e328355cf60. [DOI] [PubMed] [Google Scholar]
- 13.Drope J., Lencucha R., Magati P., Small R. Tobacco Control Governance in Sub-Saharan Africa: Implementing Article 5.2(a) of the World Health Organization Framework Convention on Tobacco Control. United Nations Development Programme and WHO FCTC Secretariat; New York, NY, USA: 2016. [(accessed on 26 August 2020)]. Available online: https://fctc.who.int/publications/m/item/tobacco-control-governance-in-sub-saharan-africa. [Google Scholar]
- 14.Kintu A., Sando D., Okello S., Mutungi G., Guwatudde D., A Menzies N., Danaei G., Verguet S. Integrating care for non-communicable diseases into routine HIV services: Key considerations for policy design in sub-Saharan Africa. J. Int. AIDS Soc. 2020;23:e25508. doi: 10.1002/jia2.25508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jaquet A., Dabis F. Smoking status and HIV in low-income and middle-income countries. Lancet Glob. Health. 2017;5:e557–e558. doi: 10.1016/S2214-109X(17)30179-1. [DOI] [PubMed] [Google Scholar]
- 16.Kharsany A.B., Karim Q.A. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016;10:34–48. doi: 10.2174/1874613601610010034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Central Statistical Office (CSO) [Zambia], Ministry of Health Zambia, and ICF International . Zambia Demographic and Health Survey 2013–2014. Central Statistical Office, Ministry of Health; Lusaka, Zambia: ICF International; Rockville, MD, USA: 2014. [(accessed on 12 July 2021)]. Available online: https://dhsprogram.com/publications/publication-fr304-dhs-final-reports.cfm?cssearch=429346_1. [Google Scholar]
- 18.Zambia Statistics Agency, Ministry of Health Zambia and ICF . Zambia Demographic and Health Survey 2018. Zambia Statistics Agency, Ministry of Health; Lusaka, Zambia: ICF; Rockville, MD, USA: 2019. [(accessed on 4 November 2020)]. Available online: https://dhsprogram.com/publications/publication-fr361-dhs-final-reports.cfm?cssearch=429346_1. [Google Scholar]
- 19.Croft T.N., Marshall A.M.J., Allen C.K., Arnold F., Assaf S., Balian S., Bekele Y., Bizimana J.d.D., Burgert C., Collison D., et al. Guide to DHS Statistics DHS-7 (Version 2) ICF; Rockville, MD, USA: 2018. [(accessed on 26 February 2021)]. Available online: https://www.dhsprogram.com/data/Guide-to-DHS-Statistics/index.cfm. [Google Scholar]
- 20.Pullum T., Staveteig S. HIV Status and Cohabitation in Sub-Saharan Africa. ICF International; Rockville, MD, USA: 2013. [(accessed on 1 February 2021)]. Available online: https://dhsprogram.com/publications/publication-as35-analytical-studies.cfm?csSearch=429366_1. [Google Scholar]
- 21.Bieler G.S., Brown G.G., Williams R.L., Brogan D.J. Estimating Model-Adjusted Risks, Risk Differences, and Risk Ratios from Complex Survey Data. Am. J. Epidemiol. 2010;171:618–623. doi: 10.1093/aje/kwp440. [DOI] [PubMed] [Google Scholar]
- 22.Mdege N.D., Makumbi F.E., Ssenyonga R., Thirlway F., Matovu J.K.B., Ratschen E., Siddiqi K., Namusisi K.N. Tobacco Smoking and Associated Factors Among People Living with HIV in Uganda. Nicotine Tob. Res. 2021;23:1208–1216. doi: 10.1093/ntr/ntaa262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.U.S. Department of Health and Human Services . Smoking Cessation: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Atlanta, GA, USA: 2020. [(accessed on 29 July 2021)]. Available online: https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf. [Google Scholar]
- 24.Poudel K.C., Poudel-Tandukar K., Bertone-Johnson E.R., Pekow P., Vidrine D.J. Inflammation in Relation to Intensity and Duration of Cigarette Smoking Among People Living with HIV. AIDS Behav. 2021;25:856–865. doi: 10.1007/s10461-020-03048-0. [DOI] [PubMed] [Google Scholar]
- 25.Egbe C.O., Londani M., Parry C.D.H., Myers B., Shuper P.A., Nkosi S., Morojele N.K. Tobacco use and nicotine dependence among people living with HIV who drink heavily in South Africa: A cross-sectional baseline study. BMC Public Health. 2019;19:1684. doi: 10.1186/s12889-019-8047-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Townsend L., Flisher A.J., Gilreath T., King G. A systematic literature review of tobacco use among adults 15 years and older in sub-Saharan Africa. Drug Alcohol Depend. 2006;84:14–27. doi: 10.1016/j.drugalcdep.2005.12.008. [DOI] [PubMed] [Google Scholar]
- 27.WHO . WHO Global Report on Trends in Prevalence of Tobacco Use 2000–2025. 3rd ed. World Health Organization; Geneva, Switzerland: 2019. [(accessed on 2 August 2021)]. Available online: https://www.who.int/publications/i/item/9789240039322. [Google Scholar]
- 28.Edwards S.K., Dean J., Power J., Baker P., Gartner C. Understanding the Prevalence of Smoking Among People Living with HIV (PLHIV) in Australia and Factors Associated with Smoking and Quitting. AIDS Behav. 2020;24:1056–1063. doi: 10.1007/s10461-019-02535-3. [DOI] [PubMed] [Google Scholar]
- 29.Elf J.L., Variava E., Chon S., Lebina L., Motlhaoleng K., Gupte N., Niaura R., Abrams D., Martinson N., E Golub J. Prevalence and Correlates of Snuff Use, and its Association with Tuberculosis, among Women Living with HIV in South Africa. Nicotine Tob. Res. 2019;21:1087–1092. doi: 10.1093/ntr/nty137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pampel F.C. Patterns of Tobacco Use in the Early Epidemic Stages: Malawi and Zambia, 2000–2002. Am. J. Public Health. 2005;95:1009–1015. doi: 10.2105/ajph.2004.056895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pampel F. Tobacco use in sub-Sahara Africa: Estimates from the demographic health surveys. Soc. Sci. Med. 2008;66:1772–1783. doi: 10.1016/j.socscimed.2007.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Stubbs B., Vancampfort D., Firth J., Solmi M., Siddiqi N., Smith L., Carvalho A.F., Koyanagi A. Association between depression and smoking: A global perspective from 48 low- and middle-income countries. J. Psychiatr. Res. 2018;103:142–149. doi: 10.1016/j.jpsychires.2018.05.018. [DOI] [PubMed] [Google Scholar]
- 33.Mulenga D., Siziya S., Rudatsikira E., Mukonka V.M., Babaniyi O., Songolo P., Muula A. District specific correlates for hypertension in Kaoma and Kasama rural districts of Zambia. Rural Remote Health. 2013;13:2345. doi: 10.22605/RRH2345. [DOI] [PubMed] [Google Scholar]
- 34.Siziya S., Babaniyi O., Songolo P., Nsakashalo-Senkwe M. Prevalence and correlates for tobacco smoking among persons aged 25 years or older in Lusaka urban district, Zambia. J. Public Health Epidemiol. 2011;3:43–48. [Google Scholar]
- 35.Pampel F.C. Global Patterns and Determinants of Sex Differences in Smoking. Int. J. Comp. Sociol. 2006;47:466–487. doi: 10.1177/0020715206070267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pool E.R., Dogar O., Lindsay R.P., Weatherburn P., Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst. Rev. 2016;2016:CD011120. doi: 10.1002/14651858.cd011120.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Mitton J.A., North C.M., Muyanja D., Okello S., Vořechovská D., Kakuhikire B., Tsai A.C., Siedner M.J. Smoking cessation after engagement in HIV care in rural Uganda. AIDS Care. 2018;30:1622–1629. doi: 10.1080/09540121.2018.1484070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Zambia Ministry of Health . Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection. Republic of Zambia Ministry of Health; Lusaka, Zambia: 2020. [Google Scholar]
- 39.Tsima B.M., Moedi P., Maunge J., Machangane K., Kgogwane M., Mudojwa T., Bastian J., Bilker W., Ashare R., Schnoll R., et al. Feasibility of implementing a novel behavioural smoking cessation intervention amongst human immunodeficiency virus-infected smokers in a resource-limited setting: A single-arm pilot trial. S. Afr. J. HIV Med. 2020;21:6. doi: 10.4102/sajhivmed.v21i1.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ashare R.L., Bernstein S.L., Schnoll R., Gross R., Catz S.L., Cioe P., Crothers K., Hitsman B., Marhefka S.L., McClure J.B., et al. The United States National Cancer Institute’s coordinated research effort on tobacco use as a major cause of morbidity and mortality among people with HIV. Nicotine Tob. Res. 2021;23:407–410. doi: 10.1093/ntr/ntaa155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Whitehouse E., Lai J., Golub J.E., Farley J.E. A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis. Public Health Action. 2018;8:37–49. doi: 10.5588/pha.18.0006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Hyle E.P., Naidoo K., Su A.E., El-Sadr W.M., Freedberg K.A. HIV, tuberculosis, and noncommunicable diseases: What is known about the costs, effects, and cost-effectiveness of integrated care? J. Acquir. Immune Defic. Syndr. 2014;67((Suppl. 1)):S87–S95. doi: 10.1097/QAI.0000000000000254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Brathwaite R., Addo J., Smeeth L., Lock K. A Systematic Review of Tobacco Smoking Prevalence and Description of Tobacco Control Strategies in Sub-Saharan African Countries; 2007 to 2014. PLoS ONE. 2015;10:e0132401. doi: 10.1371/journal.pone.0132401. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Restrictions apply to the availability of these data. Data were obtained with permission from the Demographic and Health Surveys (DHS) Program. Available online: https://www.dhsprogram.com (accessed on 11 February 2022).